🇺🇸 bupivacaine and epinephrine in United States

21 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Postoperative Wound Complication — 4 reports (19.05%)
  2. Skin Desquamation — 4 reports (19.05%)
  3. Infusion Site Reaction — 3 reports (14.29%)
  4. Necrosis — 2 reports (9.52%)
  5. Postoperative Infection — 2 reports (9.52%)
  6. Surgical Procedure Repeated — 2 reports (9.52%)
  7. Carotid Artery Stenosis — 1 report (4.76%)
  8. Ischaemic Stroke — 1 report (4.76%)
  9. Medical Device Complication — 1 report (4.76%)
  10. Pharmaceutical Product Complaint — 1 report (4.76%)

Source database →

bupivacaine and epinephrine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is bupivacaine and epinephrine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for bupivacaine and epinephrine in United States?

Mayo Clinic is the originator. The local marketing authorisation holder may differ — check the official source linked above.